BioFocus DPI and Procter & Gamble sign compound management agreement
Advertisement
BioFocus DPI announced that it has signed a three year compound management agreement with Procter & Gamble Co. (P&G). Under the agreement, BioFocus DPI will manage P&G’s chemical library collection. These services will be provided by BioFocus DPI’s compound management facility in South San Francisco, USA.
“We are pleased to welcome Procter & Gamble as a new client to our compound management services, joining other prestigious names such as the National Institutes of Health,” said Scott Snyder, BioFocus DPI’s Senior Director, Compound Management. “This collaboration leverages our full suite of compound services and further expands our client base.”
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Makhteshim Agan increases its holding in CSI to 60%
Producing petroleum substitutes from waste products - New pilot plant
Actavis expands presence in Russia - Purchase of majority stake in Russian manufacturing facility to strengthen position in fast growing market
Scientists discover new method of observing interactions in nanoscale systems
Solutia Acquires Phosphonates Business from Cognis
Shin-Etsu Chemical Develops New Optical Component Material for Optical Communications Parts
Jack McGuire becomes head of Whatman BioScience
New 'self-exploding' microcapsules could take sting out of drug delivery
Out of REACH - New legislation threatens medicines
Degussa: Breakthrough in hydrogen peroxide business
Dow Declares Force Majeure for Vinyl Acetate Monomer